The pharmaceutical industry has opposed most of Hillary Clinton’s proposals to bring down drug costs, but there’s one idea its chief lobbyist supports: limiting the amount that consumers have to pay out of their own pockets.
In an interview with STAT, Stephen Ubl, president and chief executive officer of Pharmaceutical Research and Manufacturers of America, the main trade group for drug companies, singled out the proposal when asked whether there were any positive ideas in the Democratic presidential front-runner’s drug prices plan.
Read Full Article »